Brief Biography: Dr Jim Vadolas Jim Vadolas received his PhD from the University of Melbourne, Department of Microbiology and Immunology, investigating in DNA vaccine technologies. In 1999, Jim undertook postdoctoral studies at the Murdoch Children’s Research Institute and 2005, became group leader of the Cell and Gene Therapy group primarily interested in the development of novel therapeutic strategies for β-thalassaemia and related β-haemoglobinopathies. A major aspect of his research is the development and evaluation of genetic-based approaches involving lentiviral gene therapy, genome editing and RNAi-based therapy. In 2017, Jim relocated his research program to the Hudson Institute of Medical Research, Monash Medical Centre, where he heads the Immunohaematology Group at the Centre for Cancer Research. Jim Vadolas is also the current Vice President of the Australasian Gene and Cell Therapy Society.